The AIDS Research Consortium of Atlanta is focusing on gay black men in its research on whether Viread (tenofovir) might work as pre-exposure prophylaxis (PREP), preventing HIV infection in negative people. Even though half of all new U.S. HIV infections are among African Americans, most AIDS drugs have been tested primarily on white people.